Skip to content

Urinary NTproBNP to reduce eye examinations in preterm infants

Urinary NTproBNP to reduce eye examinations in preterm infants - REDEXAM study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39687
Enrollment
100
Registered
2012-07-04
Start date
2012-11-06
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of prematurity

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Gestational age

Exclusion criteria

Exclusion criteria: - Lack of parental consent - infant likely to die soon - infant scheduled for early transfer to another institution without reliable ophthalmologic examinations (not applicable to the Netherlands)

Design outcomes

Primary

MeasureTime frame
100% negative predictive cut-off values for urinary NTproBNP concentrations normalized to creatinine at 2 and 4 weeks of life for threshold ROP (stage II+ or more in zone 2 or 3, or any ROP in zone 1)

Secondary

MeasureTime frame
100% negative predictive cut-off values for urinary NTproBNP concentrations normalized to creatinine at 2 and 4 weeks of life for ROP intervention (laser-/cryo surgery ) 100% negative predictive cut-off values for urinary NTproBNP concentrations at 2 and 4 weeks of life without normalization to creatinine for threshold ROP (stage II+ or more in zone 2 or 3, or any ROP in zone 1) 100% negative predictive cut-off values for urinary NTproBNP concentrations at 2 and 4 weeks of life without normalization to creatinine for ROP intervention (laser/cryo surgery)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)